Literature DB >> 25694437

The association between skin autofluorescence and vascular complications in Chinese patients with diabetic foot ulcer: an observational study done in Shanghai.

Chuanbo Liu1, Liying Xu2, Hui Gao3, Junna Ye1, Yao Huang4, Minjie Wu4, Ting Xie4, Pengwen Ni4, Xiaoping Yu1, Yemin Cao2, Shuliang Lu5.   

Abstract

The tissue accumulation of advanced glycation end products (AGEs) can be noninvasively assessed as skin autofluorescence (SAF) by the AGE Reader(TM) device. We aimed to detect the association between SAF and diabetes-associated vascular complications in diabetic foot ulcer (DFU) patients engaged in this study. This cross-sectional survey consisted of 118 consecutive hospitalized diabetic foot patients. The diabetic microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular referring to coronary heart disease (CHD), cerebrovascular disease (CVD), or peripheral artery disease (PAD) complications were evaluated, and then they were divided into different subgroups based on the assessment of vascular complications. As seen from the results, the mean SAF value was 2.8 ± 0.2 AU. SAF was significantly associated with diabetes duration and blood urea nitrogen (R(2) = 62.8%; P < .01). Moreover, in logistic regression analysis, SAF was significantly associated with retinopathy (odds ratio [OR] = 40.11), nephropathy (OR = 8.44), CHD (OR = 44.31), CVD (OR = 80.73), and PAD (OR = 5.98 × 10(9)). In conclusion, SAF, reflecting tissue accumulation of AGEs, is independently associated with the presence of vascular complications in DFU patients.
© The Author(s) 2015.

Entities:  

Keywords:  diabetic foot ulcer; skin autofluorescence; vascular complications

Mesh:

Year:  2015        PMID: 25694437     DOI: 10.1177/1534734614568375

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  8 in total

1.  Within- and Between-Body-Site Agreement of Skin Autofluorescence Measurements in People With and Without Diabetes-Related Foot Disease.

Authors:  Malindu E Fernando; Robert G Crowther; Peter A Lazzarini; Kunwarjit S Sangla; Scott Wearing; Petra Buttner; Jonathan Golledge
Journal:  J Diabetes Sci Technol       Date:  2019-06-16

Review 2.  Role of miRNAs in diabetic neuropathy: mechanisms and possible interventions.

Authors:  Prabhsimran Kaur; Sushil Kotru; Sandeep Singh; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.590

Review 3.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

4.  Association between diabetic foot ulcer and diabetic retinopathy.

Authors:  Duck Jin Hwang; Kyoung Min Lee; Moon Seok Park; Sung Hee Choi; Ji In Park; Joon Hee Cho; Kyu Hyung Park; Se Joon Woo
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

Review 5.  Recent Advances and the Potential for Clinical Use of Autofluorescence Detection of Extra-Ophthalmic Tissues.

Authors:  Jonas Wizenty; Teresa Schumann; Donna Theil; Martin Stockmann; Johann Pratschke; Frank Tacke; Felix Aigner; Tilo Wuensch
Journal:  Molecules       Date:  2020-04-30       Impact factor: 4.411

6.  Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis.

Authors:  Mahboobeh Sadat Hosseini; Zahra Razavi; Amir Houshang Ehsani; Alireza Firooz; Siamack Afazeli
Journal:  EClinicalMedicine       Date:  2021-11-16

Review 7.  Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.

Authors:  Bernardina T Fokkens; Andries J Smit
Journal:  Glycoconj J       Date:  2016-06-10       Impact factor: 2.916

Review 8.  Oxidative stress and antioxidant treatment in patients with peripheral artery disease.

Authors:  Panagiotis Koutakis; Ahmed Ismaeel; Patrick Farmer; Seth Purcell; Robert S Smith; Jack L Eidson; William T Bohannon
Journal:  Physiol Rep       Date:  2018-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.